Background: There is a discrepancy between the reported increase in donor conversion rates and the number of organs available for transplant. Methods: Secondary analysis of data obtained from the Scientific Registry of Transplant Recipients from January 2003 through December 2015 was performed. The primary outcomes were the (1) number of brain-dead donors from whom solid organs were recovered and (2) number of the organs transplanted. Descriptive statistics and growth plots were used to examine the trajectory of organ donation, recovery, and transplantation outcomes over the 11-year period. 
Introduction
Deceased donor-eligible donation remains the primary source of life-saving and enhancing transplants. However, the waiting list grows yearly and is now 115 000 with 20 transplant candidates dying daily while waiting. 1 In a bid to provide enough life-saving organs to this ever-increasing number of patients, a series of laws and policies have been enacted over the years in addition to changes to allocation algorithms and a major revision to the Uniform Anatomical Gift Act. [2] [3] [4] [5] [6] [7] [8] With the possible exception of First Person Authorization legislation, these efforts have not meaningfully increased the supply of transplantable organs. 9, 10 Other efforts to increase the donor supply have met with some success. One of the largest initiatives, the Organ Donation Breakthrough Collaborative sponsored by the Health Services and Resources Administration (HRSA), realized a 19% increase in family authorization from 2003 to 2007 (58%-69%) and a 25.2% increase in deceased donors (6457-8085). 1, 11 These changes relied on hospital and organ procurement organization (OPO) best practices to identify potential donors, obtain authorization from patient families, and successfully recover and place transplantable organs. 12 Many of the collaborative approaches were derived from HRSA-supported research grants to develop evidence-based interventions to increase family authorization. 13 Since the end of the collaborative in 2006, OPO-reported consent/authorization rates for organ donation (rate of consent/ authorizations obtained from eligible deaths) and concomitant conversion rates (rate of donors recovered from eligible deaths) have continued to rise. Conversion rates reached an average of 72.6% (2011) (2012) (2013) (2014) (2015) , well within range of the 75% targeted goals of HRSA's Division of Transplantation for OPOs. 14 Despite these increases in consent/authorization and conversion rates, the total number of deceased organ donors recovered in the United States stabilized at approximately 8000 per year. The modest increase to 9080 recovered in 2015, a 5.6% increase from the 8596 donors recovered in 2014, is an exception. 1 It is unclear whether this increase was due to improvements in patient identification and referral processes, improvements in family approach, increases in donor designation, or some other reason. Thus, the well-documented discrepancy between increasing authorization and conversion rates and the stagnating number of deceased donors annually have yet to be explained. This study examines the discrepancy between the steep increase in reported conversation rates, the number of organs available for transplant, and the implications for the availability of US donor organs.
Materials and Methods

Data Source
Donation outcome data from January 1, 2003, through December 31, 2015, were obtained on the 58 US OPOs, including reported eligible deaths, conversion rates, total donors, donation after brain death (DBD) donors, and DBD-transplanted organs. These administrative data are available from the Organ Procurement and Transplantation Network (OPTN) through the Scientific Registry of Transplant Recipients administered by the Chronic Disease Research Group of the Minneapolis Medical Research Foundation under contract to HRSA. This registry is the national repository of data supporting ongoing evaluation of solid organ transplantation in the United States. 1 
Primary Outcomes
The primary outcome variables were the total number of (1) deceased DBD donors from whom solid organs were recovered and (2) DBD organs transplanted. The main determining variables of interest were the number of reported eligible deaths in the DBD donor pool, DBD authorization rates, and conversion rates. Eligible deaths are, by definition, patients who have been pronounced brain dead.
As defined by the OPTN in 2013, an eligible donor "is 75 years old or less who is legally declared dead by neurologic criteria according to state or local law, has a body weight of 5 kg or greater, a body mass index of 50 kg/m 2 or less, and has at least 1 kidney, liver, heart, or lung that is deemed to meet the eligible data definition" (see )We used OPOreported eligible deaths and DBD donors; donation after cardiac death (DCD) donors were excluded from these analyses as they do not conform to the eligibility definition and because the DBD noneligible potential donor pool is not well defined.
Analytic Plan
Descriptive statistics were computed for all variables including means, standard deviations, minimums, and maximums to examine the trajectory of DBD organ donation eligibility authorization, recovery, and transplantation outcomes over a 12-year period (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) . Growth plots visually depict the rate of change over time. 16 Upon establishing patterns of stability and/or change in the indicators of interest, our analyses explored relationships among the donor pool metrics, the number of DBD donors, and the total number of organs transplanted. Table 1 presents all relevant organ donation data from 2003 to 2015 averaged over all 58 OPOs. In 2003, the average consent/ authorization rate was 56.6%. There was considerable variability in rates between OPOs, with a standard deviation (SD) for consent/authorization of 11.8 and a reported range in rates of 35% to 100%. In subsequent years, the consent/authorization rate increased by roughly 20% (to 74.8% on average in 2015). To understand the relationship of declining DBD eligibility and increasing conversion rates over time, a baseline average for reported eligible deaths (n ¼ 11 327) was computed using data from 2003 to 2005. We aligned the baseline average eligible death value with reported eligible deaths for all years subsequent to 2005. Subtracting the reported eligible deaths from the baseline average yielded an estimate of the potential annual DBD donors who would have been in the donor pool had eligibility counts remained static (ie, unrealized DBD eligible deaths). The annual reported conversion rate was multiplied by the unrealized eligible value to obtain the number of additional DBD donors that could have been recovered if eligibility numbers had remained static and reported conversion rates had been realized. Finally, we multiplied this unrealized DBD donor value by the average number of organs per DBD donor (3.18 ) to obtain the number of additional organs that were not realized.
Results
This analysis revealed a widening difference between OPOreported eligible deaths and the unrealized eligibility counts (see Figure 1) . In 2006, the difference would have been relatively negligible (3.3%); however, by 2010 to 2011, the differential climbs to 20%, representing a 506% increase in the gap between DBD eligible deaths and unrealized eligibility counts from 2006 to 2015.
The impact of the decreases in OPO-reported eligibility counts was seen in the rising number of unrealized eligible 
Discussion
Donor Trends
Revisions to laws, policies, and regulations of the donation system are intended to increase the availability of transplantable organs to patients in desperate need. Recent trends in authorization and conversion have presented a conundrum. Although rates have risen, at times dramatically, the absolute numbers of available organs have risen only modestly. As we presented, the 2004 conversion rate was 56.8%. By comparison, in 2015, the conversion rate was 72.1%, an increase of 27%. The concomitant increase in DBD donors was only 12.3%. The core of this article is to understand this seeming contradiction. Table 2 ). These analyses did not factor in any increase in population and/or deaths. A recent national study of donor potential noted an unrealized potential across all demographic groups, with the most significant (70%) in the 50-75-year-old age-group; this study included potential DCD donors. 18 The growth in total organ donors (DBD and DCD), from 8017 in 2006 to 9079 in 2015, resulted almost entirely from donors that fall outside the definition of "eligible" (ie, DCD and extended criteria donors). Historically, approximately one-third of patients who die from traumatic brain injury (TBI) progress to brain death, accounting for the single largest contribution of organs acquired from deceased donation. 19 However, studies of the donor pool indicate a shift in donor patterns from brain-dead donors to DCD. Although every organ matters when lives are saved, reliance on these nontraditional donors is not a comprehensive solution to the organ shortage. Donors from DCD result in fewer extrarenal organs recovered and provide no benefit to waitlisted heart and lung candidates. The benefit for liver candidates is also much less than with DBD donors, although evolving. 20 Extended criteria donors, mostly patients in older age groups present challenges to both OPOs and transplant programs because of comorbid conditions affecting organ quality, lower numbers of organs transplantable per donor, and higher discard rates. 18 One investigation noted a 10-fold increase in DCD and a decline in trauma/TBI donors at a single hospital from 1998 and 2008. 21 During this same time period, the number of donors with cerebrovascular disease increased from 57% to 74%; DCD from cerebrovascular disease accounted for 60% of all donors in this study. 22 A significant rise in surgical interventions administered to braininjured patients was postulated to account for the reduction in progression to brain death. 22 The increase in DCD was cited as reason for fewer organs per donor recovered. Overall, these shifts likely do not account for the dramatic drop in the donor pool, as this trend was in evidence during the period of the most dramatic rise in the numbers of individuals reported as eligible donors (see Table 1 ). Moreover, a recent examination of mortality data revealed an increase in accidental deaths, but a decrease in deaths due to cerebrovascular diseases.
Unrealized Donors
22,23
Current Inadequacies in Defining Patient Eligibility and Policy Implications
As modified by the OPTN in 2013, the current definition of an eligible donor excludes patients who may be brain dead but are not formally pronounced and documented (see Box 1) . 15 The failure to formally pronounce brain death may be due to a decision to withdraw supportive care prior to discussing donation with the family or staff belief that the family is unlikely to agree to donation. This critical flaw in the definition of eligible deaths fails to accurately reflect the potential donor pool within the population. Moreover, the US health-care financing system encourages hospitals to move more aggressively to withdraw treatment unless there is an immediately clear and affirmative indication by the family to donate. One study found that individuals who did not donate believed they had without understanding that withdrawal of mechanical supports precluded donation. 24 Complicating matters, several states require 2 neurological examinations within a specified time frame. If the first examination is conducted and the family receives poor prognostic information and expresses an intent to refuse donation, there is no incentive to proceed with the second examination and the formal pronouncement of brain death. The patient who, for all intents and purposes, is brain dead will be classified as ineligible and not included in the denominator for calculation of the authorization/conversion rate. Excluding patients who are likely brain dead from the donor pool, for whatever reason, undermines credibility in the conversion rate metric. Conversion rates, which serve as an indicator of how well the donor service area (DSA) as a whole is performing, are then inflated while the donor pool is undercounted.
The ambiguous denominator makes benchmarking a flawed, tenuous, and ultimately futile effort. Others note the inadequacy of using eligible death as a descriptor of the potential donor pool. Better measures are needed to accurately and reliably assess industry performance. However, achieving a better measure is "complicated by the inevitable dual purpose for which data is used: performance improvement and CMS redesignation. The fear of the latter inhibits the former, much as concerns with CMS transplant center performance measurement impacts centers' willingness to use certain organs." 25, (pp 2020) Optimization of organ donation potential is the best strategy for increasing the number of organs available for transplantation. 26 The impact of both the eligible definition and its application to determine eligibility has resulted in an artificial depression of the pool of eligible deaths and an inaccurate picture of true donor potential in the United States. Uncertainties about the size, distribution, and recovery penetration of the US donor pool are brought into sharp focus by recent policy considerations by the OPTN, such as the redistribution of organs across broader allocation areas. The unfortunate lack of a clearly defined, routinely utilized, and independently reported indicator as the denominator for calculation of conversion rates (ie, donation rates) undermines any systematic study of the donation system and evaluation of interventions developed to improve the system.
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Unidentified/unreported eligible potential donors. The current calculation of DSA donation rates with OPO-reported eligible deaths as the denominator has implications for OPOs' overall rankings and the subsequent receipt of CMS certification, making the (mis)classification of eligible deaths a subject of great scrutiny and focus by the organization. Indeed, this single metric is used for purposes of classifying the donor potential, calculating conversion rates, and forecasting budgets, and other organizational reporting activities. This represents a conflict of interest since the data are self-reported by the OPO and are subjective, open to individual interpretation, and not independently verifiable. Organ procurement organizations have been encouraged to focus on rates, calculated using an unreliable denominator to the detriment of hard goals such as the absolute volume and increased number of actual organs recovered for transplantation. [27] [28] The ultimate goal should be to transplant the largest number of patients as possible, not to achieve an arbitrary calculated rate.
Proposed metrics. The importance of both DSA performance and the need to create new and unambiguous DSA performance metrics has increased with proposed UNOS allocation changes. In some cases, the proposed changes would send livers from DSAs with higher productivity to DSAs with lower productivity as a means of reducing perceived geographic disparities in liver transplantation. [29] [30] [31] [32] One positive result of this debate over the reallocation of resources has been an increased scrutiny of and demand for improved DSA performance and better performance metrics. Stronger, more objective metrics are needed not only to validate the algorithms used to justify the changes but also to assess the impact of the changes, 33 if implemented as currently proposed. We, therefore, call for performance measures that are calculations in which the denominator is not subject to interpretation.
Every other country in the world continues to benchmark donation rates using donors per million (DPM), an easily calculable metric which is not subject to interpretation. We advocate for the retention of DPM for historical and international benchmarking. Used in combination with a new metric, a "donors per 'x' number of deaths" in the DSA, both metrics could replace use of eligible deaths as the denominator for conversion rates. The introduction of International Classification of Diseases, Ninth Revision codes, comorbid conditions, and other such indices require more granularity than death and population and would be dependent on accurate coding and inclusion of additional confounding process variables in gathering, coding, and reporting out the data. The resulting metric would likely vary in precision across OPOs and DSAs, as would the conversion rate. Regardless of the metric chosen, it must neither allow for the possibility of subjective interpretation and modification nor affect the absolute ranking and benchmarking of individual OPOs.
The ongoing use of relative "rates" of donation derived from actual donors (numerator) over OPO-reported "eligible deaths" (denominator) is not representative of the US donor pool. Yet, we act as if it is. The lack of an independently verifiable, unambiguous denominator for calculation of donation rates undermines benchmarking and performance measurement and any attempt at system improvement. The strongly debated liver reallocation proposal makes this an ideal time for change. Rather than implementing an inherently flawed proposal with both predicted and unforeseeable consequences, we suggest redirecting the energies of the transplant industry to identifying an objective but verifiable metric that accurately reflects the current donor pool. It is not merely time we risk in delaying action, it is lives as well. Rates are not transplantable, organs are.
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